Atasever Melahat, Namlı Kalem Muberra, Sönmez Çiğdem, Seval Mehmet Murat, Yüce Tuncay, Sahin Aker Seda, Koç Acar, Genc Hakan
a Department of Gynecology and Obstetrics , Giresun University Faculty of Medicine , Giresun , Turkey.
b Department of Gynecology and Obstetrics , Turgut Ozal University Faculty of Medicine , Ankara , Turkey.
J Matern Fetal Neonatal Med. 2017 Sep;30(18):2204-2211. doi: 10.1080/14767058.2016.1243096. Epub 2016 Nov 29.
The aim of the study is to investigate the relationship between changes in serotonin levels during pregnancy and fibromyalgia syndrome (FS) and the relationships between FS and the physical/psychological state, biochemical and hormonal parameters, which may be related to the musculoskeletal system.
This study is a prospective case-control study conducted with 277 pregnant women at the obstetric unit of Ankara University Faculty of Medicine, in the period between January and June 2015. FS was determined based on the presence or absence of the 2010 ACR diagnostic criteria and all the volunteers were asked to answer the questionnaires as Fibromyalgia Impact Criteria (FIQ), Widespread Pain Index (WPI), Symptom Severity Scale (SS), Beck Depression Inventory and Visual Analog Scale (VAS). Biochemical and hormonal markers (glucose, TSH, T4, Ca (calcium), P (phosphate), PTH (parathyroid hormone) and serotonin levels) relating to muscle and bone metabolism were measured.
In the presence of fibromyalgia, the physical and psychological parameters are negatively affected (p < 0.001). There was no significant difference between the fibromyalgia and control groups in terms of glucose, Ca (calcium), P (phosphorus), PTH (parathyroid hormone), TSH (thyroid stimulant hormone), fT4 (free T4) levels (p = 0.060, 0.799, 0.074, 0.104, 0.797, 0.929, respectively). A reduction in serotonin levels may contribute to the development of fibromyalgia but this was not statistically significant. The Beck Depression Inventory scale statistically showed that increasing scores also increase the risk of fibromyalgia (p <0.001).
Our study has shown that serotonin levels in women with FS are lower than the control group and that serotonin levels reduce as pregnancy progresses. Anxiety and depression in pregnant women with FS are higher than the control group. The presence of depression increases the likelihood of developing FS at a statistically significant level. Serotonin impairment also increases the chance of developing FS, but this correlation has not been shown to be statistically significant.
本研究旨在探讨孕期血清素水平变化与纤维肌痛综合征(FS)之间的关系,以及FS与可能与肌肉骨骼系统相关的身体/心理状态、生化和激素参数之间的关系。
本研究是一项前瞻性病例对照研究,于2015年1月至6月期间在安卡拉大学医学院产科对277名孕妇进行。根据2010年美国风湿病学会(ACR)诊断标准的存在与否来确定FS,所有志愿者均被要求回答如纤维肌痛影响标准(FIQ)、广泛性疼痛指数(WPI)、症状严重程度量表(SS)、贝克抑郁量表和视觉模拟量表(VAS)等问卷。测量了与肌肉和骨骼代谢相关 的生化和激素标志物(葡萄糖、促甲状腺激素(TSH)、甲状腺素(T4)、钙(Ca)、磷(P)、甲状旁腺激素(PTH)和血清素水平)。
存在纤维肌痛时,身体和心理参数受到负面影响(p <0.001)。纤维肌痛组和对照组在葡萄糖、钙(Ca)、磷(P)、甲状旁腺激素(PTH)、促甲状腺激素(TSH)、游离甲状腺素(fT4)水平方面无显著差异(p分别为0.060、0.799、0.074、0.104、0.797、0.929)。血清素水平降低可能有助于纤维肌痛的发展,但这在统计学上并不显著。贝克抑郁量表在统计学上表明,得分增加也会增加患纤维肌痛的风险(p <0.001)。
我们的研究表明,患有FS的女性血清素水平低于对照组,且血清素水平随着孕期进展而降低。患有FS的孕妇的焦虑和抑郁程度高于对照组。抑郁的存在会使患FS的可能性在统计学显著水平上增加。血清素损伤也会增加患FS的几率,但这种相关性尚未显示出统计学显著性。